Melatonin improves hyperglycemia induced damages in rat brain

Area of Science:

• Endocrinology
• Neuroscience
• Biochemistry

Background:

• Diabetes mellitus is characterized by insulin resistance or deficiency, leading to hyperglycemia, inflammation, and oxidative stress.
• Oxidative stress is implicated in the development of diabetic complications.
• Melatonin is a hormone known to interact with insulin in the context of diabetes.

Purpose of the Study:

• To investigate the effects of melatonin treatment, with and without insulin, on the brains of diabetic rats.
• To assess the impact of melatonin and insulin on oxidative stress markers in the diabetic brain.

Main Methods:

• Experimental diabetes was induced in rats using streptozotocin.
• Rats were divided into five groups: control, diabetes, diabetes + insulin, diabetes + melatonin, and diabetes + melatonin + insulin.
• Brain tissue was analyzed for levels of malondialdehyde, glutathione, sialic acid, nitric oxide, and activities of superoxide dismutase, catalase, glutathione-S-transferase, myeloperoxidase, and tissue factor.

Main Results:

• Melatonin alone increased glutathione, superoxide dismutase, catalase, and glutathione-S-transferase activities, while decreasing malondialdehyde levels in diabetic rat brains.
• Insulin showed similar effects to melatonin on lipid peroxidation, superoxide dismutase, and catalase, and also decreased myeloperoxidase activity and increased tissue factor activity.
• Combined melatonin and insulin treatment produced effects similar to insulin alone.

Conclusions:

• Melatonin exhibits significant antioxidant effects in the diabetic rat brain.
• The addition of melatonin to insulin treatment did not alter insulin's effects.
• Further experimental and clinical studies are warranted to elucidate the specific role of melatonin in diabetes treatment.